Generics - AstraZeneca, Neurological

Filter

Current filters:

AstraZenecaNeurological

Popular Filters

US Court of Appeals confirms validity of AstraZeneca' Seroquel XR patent

15-02-2013

AstraZeneca announced that, on 14 February 2013, the United States Court of Appeals for the Federal Circuit…

AstraZenecaGenericsLegalNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XR

Watson debuts generic Nexium in Europe; Mylan launches Amidate copy in USA

08-08-2012

US generics firm Watson Pharmaceuticals (NYSE: WPI) said yesterday that its third-party business Specifar…

AmidateAstraZenecaEuropeGastro-intestinalsGenericsHospiraMarkets & MarketingMylan LaboratoriesNeurologicalNexiumNorth AmericaRegulationWatson Pharmaceuticals

Slow-down of European bipolar therapy market set for short-term slowdown

04-07-2012

Patent expiry of key blockbuster atypical antipsychotic drugs is likely to cause a decline in growth…

AstraZenecaEuropeGenericsMarkets & MarketingNeurologicalPatentsPharmaceuticalPricingSeroquel

US Court upholds AstraZeneca Seroquel XR patent

30-03-2012

In some good news for the company, Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced last night…

Anchen PharmaceuticalsAstraZenecaGenericsMylan LaboratoriesNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XRTorrent Pharmaceuticals

US court turns down AstraZeneca FDA injunction; Teva debuts generic Seroquel in UK

26-03-2012

In another setback for Anglo-Swedish drug major AstraZeneca in its fight to delay generic competition…

AstraZenecaEuropeGenericsLegalNeurologicalNorth AmericaPatentsPharmaceuticalRegulationSeroquelSeroquel XR

Actavis reportedly to be acquired by Watson; debuts generic Zomig

22-03-2012

Icelandic generic drugmaker Actavis is said to be in talks to be acquired by US peer Watson Pharmaceuticals…

ActavisAstraZenecaEuropeGenericsMarkets & MarketingMergers & AcquisitionsNeurologicalPatentsWatson PharmaceuticalsZolmitriptanZomig

AstraZeneca in patent settlement deal with Handa over Seroquel XR

30-09-2011

Anglo-Swedish drug major AstraZeneca (LSE: AN) yesterday revealed that it has entered into a settlement…

AstraZenecaGenericsHanda PharmaceuticalsNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XR

Back to top